Bourque, J. M., Velazquez, E. J., Tuttle, R. H., Shaw, L. K., Lee, K. L., O’Connor, C. M., & Borges-Neto, S. (2004). 1056-163 Duke viability index predicts long-term mortality in patients with ischemic cardiomyopathy independent of treatment allocation. In Journal of the American College of Cardiology (Vol. 43, pp. A325–A325). Elsevier BV. https://doi.org/10.1016/s0735-1097(04)91375-7

Bourque, Jamieson M., Eric J. Velazquez, Robert H. Tuttle, Linda K. Shaw, Kerry L. Lee, Christopher M. O’Connor, and Salvador Borges-Neto. “1056-163 Duke viability index predicts long-term mortality in patients with ischemic cardiomyopathy independent of treatment allocation.” In Journal of the American College of Cardiology, 43:A325–A325. Elsevier BV, 2004. https://doi.org/10.1016/s0735-1097(04)91375-7.

Bourque JM, Velazquez EJ, Tuttle RH, Shaw LK, Lee KL, O’Connor CM, et al. 1056-163 Duke viability index predicts long-term mortality in patients with ischemic cardiomyopathy independent of treatment allocation. In: Journal of the American College of Cardiology. Elsevier BV; 2004. p. A325–A325.

Bourque, Jamieson M., et al. “1056-163 Duke viability index predicts long-term mortality in patients with ischemic cardiomyopathy independent of treatment allocation.” Journal of the American College of Cardiology, vol. 43, no. 5, Elsevier BV, 2004, pp. A325–A325. Crossref, doi:10.1016/s0735-1097(04)91375-7.

Bourque JM, Velazquez EJ, Tuttle RH, Shaw LK, Lee KL, O’Connor CM, Borges-Neto S. 1056-163 Duke viability index predicts long-term mortality in patients with ischemic cardiomyopathy independent of treatment allocation. Journal of the American College of Cardiology. Elsevier BV; 2004. p. A325–A325.